Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Serena Apollinari"'
Autor:
Pasquale Sperlongano, Elena Bestoso, Gabriella Misso, Pierosandro Tagliaferri, C. Botta, Alberto Abbruzzese, Pierfrancesco Tassone, Serena Apollinari, Pierpaolo Pastina, Maria Grazia Cusi, Pierpaolo Correale, Michele Caraglia
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 35(5)
Cetuximab is a human-murine chimeric monoclonal antibody to the epidermal growth factor receptor, active for advanced colorectal cancer treatment in combination with chemotherapy. Cetuximab mainly acts by inhibiting epidermal growth factor receptor-m
Autor:
Chiara Ginanneschi, Pierosandro Tagliaferri, Pierfrancesco Tassone, Maria Teresa Del Vecchio, Serena Apollinari, Antonella Licchetta, Cirino Botta, Fabio De Luca, Raffaele Conca, Maria Saveria Rotundo, Pierpaolo Correale
Purpose: An efficient adaptive immunity is critical for a longer survival in cancer. We investigated the prognostic value of tumor infiltration by CD8+ T cells expressing the chemokine-receptor-7 (Tccr7) and the correlation between tumor infiltration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc11ca2b40570495d5f15afc15eb8433
http://hdl.handle.net/10447/512521
http://hdl.handle.net/10447/512521
Autor:
M. M. De Santi, Elena Bestoso, Mario Turriziani, Susanna Mannucci, Alberto Abbruzzese, M. Marra, Serena Apollinari, M. Del Vecchio, Pierosandro Tagliaferri, Angelo Aquino, C. Botta, Michele Caraglia, G. Gori Savellini, Pierpaolo Correale, Laura Bonmassar, Maria Grazia Cusi
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor receptor, approved for colorectal carcinoma treatment in combination with chemotherapy. The immune-mediated effects elicited by its human fraction of crysta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af169797f3d20eeb7b02256649ee9761
http://hdl.handle.net/11365/23653
http://hdl.handle.net/11365/23653
Autor:
Michele Caraglia, Serena Apollinari, Ornella Romano, Marco Pagliuchi, Cirino Botta, Ignazio Martellucci, Raffaele Addeo, Luca Luzzi, Gabriella Misso, Pierpaolo Correale, Giuseppe Gotti, Elena Bestoso, Pierosandro Tagliaferri, Maria Saveria Rotundo, Assunta Basile, Monica Lamberti, Antonella Licchetta, Alberto Abbruzzese
Publikováno v:
Cancer biologytherapy. 12(2)
Bevacizumab, is a humanized monoclonal antibody to vasculo-endothelial- growth-factor, with anticancer activity in non-small-cell-lung cancer (NSCLC) patients. Our previous results from a dose/finding phase I trial in NSCLC patients, demonstrated the
Autor:
Pierosandro Tagliaferri, Serena Apollinari, Marco Pagliuchi, Assunta Basile, Pierpaolo Pastina, Veronica Ricci, Federico Chellini, Antonella Fioravanti, Luigi Pirtoli, Elena Bestoso, Maria Grazia Cusi, Salvatore Carbone, Gianni Gori Savellini, Maria Grazia Rossetti, Giacomo Maria Guidelli, Pierpaolo Correale, Cirino Botta, Giovanni Mantovani
Publikováno v:
Journal of Clinical Oncology. 30:e13098-e13098
e13098 Background: TSPP is a poly-epitope peptide anticancer vaccine able to generate a thymidylate syntase (TS) specific T cell response with antitumor activity in preclinical models, expecially when used in sequential combination with 5-FU. TS is i
Autor:
Federico Chellini, Pierpaolo Pastina, Giacomo Maria Guidelli, Pierosandro Tagliaferri, Maria Grazia Cusi, Marco Pagliuchi, Cirino Botta, Pierpaolo Correale, Gianni Gori Savellini, Elena Bestoso, Maria Grazia Rossetti, Maria Assunta Basile, Antonella Fioravanti, Luigi Pirtoli, Serena Apollinari
Publikováno v:
Cancer Research. 72:LB-229
Background TSPP is a poly-epitope peptide vaccine to the thymidylate syntase (TS) an enzyme commonly over-expressed in replicating cancer cells and recognized as a major target of fluoropyrimidines. TSPP showed immunological and anticancer activity i
Autor:
A. Aquino, Elena Bestoso, Alberto Abbruzzese, M. Del Vecchio, Pierosandro Tagliaferri, C. Botta, P. Correale, Michele Caraglia, Maria Grazia Cusi, Serena Apollinari
Publikováno v:
European Journal of Cancer. 47:S434
6140 POSTER Cetuximab-mediated Immune-enhancing Effects in Vitro and in Metastatic Colorectal Cancer (mCRC) Patients P. Correale1, C. Botta1, M.G. Cusi2, E. Bestoso1, S. Apollinari1, M. Caraglia3, M.T. Del Vecchio4, A. Abbruzzese3, A. Aquino5, P. Tag
Publikováno v:
European Journal of Cancer. 47:S634
Autor:
Vito Barbieri, P. Correale, Pierfrancesco Tassone, Antonella Licchetta, C. Botta, P. Blardi, Annamaria Guglielmo, Giovanni Mantovani, G. Chiriaco, Serena Apollinari, Pierosandro Tagliaferri, Elena Bestoso
Publikováno v:
Journal of Clinical Oncology. 29:7582-7582
7582 Background: At present, there is a great concern for the toxicity and costs associated with anti-VEGF Bevacizumab (Bv) mAb use in lung cancer treatment, underscoring the need of biomarkers pre...
Autor:
Domenico Ciliberto, Pierosandro Tagliaferri, M. Del Vecchio, Elena Bestoso, Pierfrancesco Tassone, C. Botta, Serena Apollinari, Maria Saveria Rotundo, P. Correale
Publikováno v:
Journal of Clinical Oncology. 29:e14056-e14056
e14056 Background: An efficient anti-tumor immune-response is considered a critical factor for a good outcome and a prolonged survival in colorectal cancer patients. The extent of tumor infiltratio...